Oruka Therapeutics Inc. (Nasdaq: ORKA), a clinical-stage biotechnology company focused on novel treatments for chronic skin diseases like plaque psoriasis, will participate in multiple upcoming healthcare and biotech conferences. The company is scheduled to present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12th, 2026, at 10:30AM ET; the TD Cowen 46th Annual Health Care Conference on March 3rd, 2026, at 1:10PM ET; the UBS Biotech Summit Miami on March 9th, 2026; the Jefferies Biotech on the Beach Summit on March 10th, 2026; the Leerink Global Healthcare Conference on March 11th, 2026, at 1:00PM ET; and the Barclays 28th Annual Global Healthcare Conference on March 12th, 2026, at 10:30AM ET. A webcast and replay of Oruka's presentations will be available on the Oruka investor events website at https://ir.orukatx.com/news-events/events-presentations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9650947-en) on February 09, 2026, and is solely responsible for the information contained therein.